22:45 , Apr 29, 2019 |  BC Extra  |  Financial News

April 29 Quick Takes: Sirnaomics, Codiak, Cortexyme, Milestone, NextCure, Applied Therapeutics, Magenta

Sirnaomics closes $47M series C  RNAi therapeutics company Sirnaomics Inc. (Gaithersburg, Md.) raised $22 million in a series C2 round led by Hong Kong-based CR-CP Life Sciences Fund, closing out its series C round for...
21:34 , Apr 19, 2019 |  BC Week In Review  |  Clinical News

Eiger raises $49.5M following Phase II HDV readout for Lambda

Eiger reported data from the Phase II LIMT HDV trial showing that high-dose Lambda as monotherapy led to a 36% durable virologic response rate at 24 weeks following treatment among 14 evaluable patients with chronic...
22:53 , Apr 5, 2019 |  BC Extra  |  Company News

Management tracks: Zealand taps Alnylam’s Dulac as CEO, plus ICER, Jnana and more

Emmanuel Dulac is leaving his post as chief international strategy officer of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) to become the new CEO of Zealand Pharma A/S (CSE:ZEAL; NASDAQ:ZEAL), effective April 22. Dulac succeeds Adam Steensberg, the...
14:23 , Mar 20, 2019 |  BC Extra  |  Financial News

Follow-on roundup: Dermira, resTORbio, NanoString

Dermira raised $130 million in an upsized offering that followed closely after its eczema readout this week, while resTORbio and NanoString also priced follow-ons late Tuesday. Dermira Inc. (NASDAQ:DERM) sold 9.8 million shares at $13.25,...
21:44 , Feb 12, 2019 |  BC Extra  |  Company News

Management tracks: Sanofi, Alexion, bluebird

Sanofi (Euronext:SAN; NASDAQ:SNY) said Ameet Nathwani will become the pharma's first chief digital officer in addition to his current role of EVP, CMO. Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said SVP, Business Development and Corporate Strategy Aradhana...
22:48 , Dec 20, 2018 |  BC Extra  |  Company News

Management tracks: Evox names Moses chairman; Kapeller joins GV

Exosome therapy company Evox Therapeutics Ltd. (Oxford, U.K.) appointed Edwin Moses as chairman. This month, the former Ablynx N.V. CEO was also appointed chairman of Virion Biotherapeutics Ltd. (London, U.K.) and Achilles Therapeutics Ltd. (Stevenage,...
18:28 , Nov 9, 2018 |  BC Week In Review  |  Financial News

Sarepta collects half a billion in follow-on

Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $500 million late on Nov. 8 through the sale of 3.8 million shares at $131. The price is a 9% discount to Sarepta's close of $144.06 on Nov. 7, when...
00:54 , Nov 9, 2018 |  BC Extra  |  Financial News

Sarepta collects half a billion in follow-on

Sarepta Therapeutics Inc. (NASDAQ:SRPT) raised $500 million late Thursday through the sale of 3.8 million shares at $131. The price is a 9% discount to Sarepta's close of $144.06 on Wednesday, when it proposed the...
20:04 , Nov 2, 2018 |  BC Week In Review  |  Financial News

Twist raises $70M in NASDAQ IPO

Twist Bioscience Corp. (NASDAQ:TWST) raised $70 million in an IPO of 5 million shares at $14 on Oct. 31. The price values the DNA synthesis company at $372.5 million. Twist had proposed to sell 5...
17:36 , Sep 28, 2018 |  BC Week In Review  |  Clinical News

Alexion eyes submissions for Soliris in rare CNS disease

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) plans to submit regulatory applications in the U.S., EU and Japan for Soliris eculizumab to treat relapsing neuromyelitis optica spectrum disorder (NMOSD) after the drug met the primary endpoint in the...